Brief: PharmaCyte Biotech Says Registered Direct Offering Of $70 Million
19/08/2021 12:42
Aug 19 (Reuters) - PharmaCyte Biotech Inc PMCB.O :
* PHARMACYTE BIOTECH ANNOUNCES $70 MILLION REGISTERED DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
* PHARMACYTE BIOTECH - AGREED TO ISSUE TO INVESTORS
UNREGISTERED
WARRANTS TO PURCHASE UP TO AN AGGREGATE 7 MILLION SHARES OF
COMMON STOCK
Source text for Eikon: ID:nBw8Wp5VZa
Further company coverage: PMCB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer